Review
Accepted on 11 Feb 2025
Targeting cGAS-STING: Modulating the Immune Landscape of Hepatic Diseases
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1498323
Type at least 3 characters
7,152 articles
Articles
Original Research
Accepted on 11 Feb 2025
Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1513806
Original Research
Accepted on 11 Feb 2025
A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosomepositive acute lymphoblastic leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1522293
Editorial
Published on 11 Feb 2025
Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563383
- 311 views
Original Research
Published on 11 Feb 2025
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1531874
- 229 views
Review
Published on 11 Feb 2025
RIPK1 in necroptosis and recent progress in related pharmaceutics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1480027
- 488 views
Original Research
Published on 11 Feb 2025
Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1470432
- 572 views
Original Research
Published on 11 Feb 2025
Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients - the IMMUNYON study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1516793
- 353 views
Original Research
Accepted on 10 Feb 2025
Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: A single-arm clinical study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532460
Original Research
Accepted on 10 Feb 2025
Raman Spectroscopy and Bioinformatics-based Identification of Key Genes and Pathways Capable of Distinguishing Between Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1516946
- 101 views
Original Research
Accepted on 10 Feb 2025
Unveiling SSR4: A Promising Biomarker in Esophageal Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544154
Review
Accepted on 10 Feb 2025
Impact of cannabinoid-based medicines on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1497829
Original Research
Accepted on 10 Feb 2025
Development of a Tertiary Lymphoid Structure-Based Prognostic Model for Breast Cancer: Integrating Single-Cell Sequencing and Machine Learning to Enhance Patient Outcomes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1534928
Original Research
Accepted on 10 Feb 2025
Integrative Analysis of Semaphorins Family Genes in Colorectal Cancer: Implications for Prognosis and Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1536545
Review
Accepted on 10 Feb 2025
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1526967
Case Report
Accepted on 10 Feb 2025
Case report: Complete response to four cycles of camrelizumab in a PD-L1 negative patient with advanced oral squamous cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1476455